A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study to Investigate the Effect of JNJ-18054478 in Subjects With Asthma.
Phase of Trial: Phase II
Latest Information Update: 26 Jun 2014
At a glance
- Drugs JNJ 18054478 (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Janssen Research & Development
- 11 Sep 2009 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 11 Sep 2009 Actual patient number (133) added as reported by ClinicalTrials.gov.
- 31 Jul 2008 Status changed from recruiting to in progress based on information from ClinicalTrials.gov.